Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga
Status:
Completed
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether in patients with early type 2 diabetes, a
short-term intensive metabolic intervention comprising Forxiga, metformin, basal insulin
glargine and lifestyle approaches will be superior to standard diabetes therapy in achieving
sustained diabetes remission.